Article
Biochemistry & Molecular Biology
Julia D. Vavilova, Maria O. Ustiuzhanina, Anna A. Boyko, Maria A. Streltsova, Sofya A. Kust, Leonid M. Kanevskiy, Rustam N. Iskhakov, Alexander M. Sapozhnikov, Ekaterina O. Gubernatorova, Marina S. Drutskaya, Mikhail V. Bychinin, Oksana N. Novikova, Anna G. Sotnikova, Gaukhar M. Yusubalieva, Vladimir P. Baklaushev, Elena I. Kovalenko
Summary: The activation and differentiation of NKT-like cells and CD56(-) T cells in COVID-19 patients were analyzed. Severe COVID-19 was associated with a decrease in CD8(+) T cells and a shift towards more differentiated cytotoxic CD8(+) T cells. COVID-19 progression was indicated by decreased percentages of NKG2D(+) and NKG2A(+) cells and increased PD-1 and HLA-DR expression levels in both CD56(-) and CD56(+) T cells.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Biochemistry & Molecular Biology
Nicola Mitwasi, Claudia Arndt, Liliana R. Loureiro, Alexandra Kegler, Frederick Fasslrinner, Nicole Berndt, Ralf Bergmann, Vaclav Horejsi, Claudia Roessig, Michael Bachmann, Anja Feldmann
Summary: This paper investigates the use of CD10 as a therapeutic target and addresses the challenges in improving CAR T-cell therapy for B-ALL.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Immunology
Marius Schwabenland, Henrike Salie, Jovan Tanevski, Saskia Killmer, Marilyn Salvat Lago, Alexandra Emilia Schlaak, Lena Mayer, Jakob Matschke, Klaus Puschel, Antonia Fitzek, Benjamin Ondruschka, Henrik E. Mei, Tobias Boettler, Christoph Neumann-Haefelin, Maike Hofmann, Angele Breithaupt, Nafiye Genc, Christine Stadelmann, Julio Saez-Rodriguez, Peter Bronsert, Klaus-Peter Knobeloch, Thomas Blank, Robert Thimme, Markus Glatzel, Marco Prinz, Bertram Bengsch
Summary: The study found profound neuroinflammation in COVID-19 patients, with activation of innate and adaptive immune cells. These pathological changes are associated with systemic inflammation and disturbed hemostasis, suggesting potential therapeutic strategies.
Review
Medicine, General & Internal
Kerstin N. Vokinger, Miquel Serra-Burriel, Camille E. G. Glaus, Ulrich-Peter Rohr, Thomas J. Hwang, Simon Dalla Torre di Sanguinetto, Aaron S. Kesselheim
Summary: The research assessed the regulatory review duration of drug regulatory agencies in the United States and Europe, and found that the review duration in Europe is generally longer than in the United States and Switzerland. The study also revealed that the European Medicines Agency took longer than the U.S. Food and Drug Administration to review drugs, and there were differences in submission times between the United States and Europe.
ANNALS OF INTERNAL MEDICINE
(2023)
Article
Immunology
Michelle Wantoch, Erica B. Wilson, Alastair P. Droop, Sarah L. Phillips, Matt Coffey, Yasser M. El-Sherbiny, Tim D. Holmes, Alan A. Melcher, Laura F. Wetherill, Graham P. Cook
Summary: This study analyzed the mechanism by which reovirus modulates human NK cell activity. It was found that reovirus activates NK cells through the dependent manner of type I interferon, inducing STAT1 and STAT4 signaling, and producing different responses in CD56(dim) and CD56(bright) subsets. Moreover, reovirus treatment inhibits IL-15-induced NK cell proliferation and reduces AKT signaling. In vivo experiments also showed that CD56(bright) NK cells are transiently lost from the peripheral circulation at the peak of the IFN-I response, indicating their redistribution to secondary lymphoid tissue. The activation of both CD56(dim) and CD56(bright) NK cells by antiviral pathways induces a spectrum of activity that includes the NK cell-mediated killing of tumor cells and modulation of adaptive responses via the trafficking of IFN-gamma expressing CD56(bright) NK cells to lymph nodes.
Article
Medicine, General & Internal
Ming Liu, Guan Wang, Lin Wang, Yuqi Wang, Yuqing Bian, Hang Shi, Jie Liu
Summary: This study aimed to investigate whether CD10 was a valid biomarker for distinguishing mature and immature neutrophil subgroups under septic conditions and their immunoregulatory effects on lymphocytes. The results showed that CD10 could effectively distinguish mature and immature neutrophils, and they had opposite immunoregulatory effects on T cells.
FRONTIERS IN MEDICINE
(2023)
Editorial Material
Cell Biology
Albert Herms, Philip H. Jones
Summary: A new study reveals that keratinocytes initiate differentiation before exiting the cell cycle, enabling the skin to respond quickly to damage.
NATURE CELL BIOLOGY
(2022)
Review
Oncology
Mark P. Lythgoe, Jonathan Krell, Mark Bower, Ravindhi Murphy, John Marriott, Sarah P. Blagden, Ajay Aggarwal, Richard Sullivan
Summary: The UK's departure from the EU has led to the Medicines and Healthcare products Regulatory Agency becoming an independent national regulator. Efforts have been made to attract drug development and regulatory review to the UK by offering expedited review pathways and collaboration with international medicines regulators. This Policy Review examines the impact of new UK regulatory frameworks, policies, and global collaborations on oncology drug approvals and explores the challenges ahead.
Article
Multidisciplinary Sciences
Lena Cords, Sandra Tietscher, Tobias Anzeneder, Claus Langwieder, Martin Rees, Natalie de Souza, Bernd Bodenmiller
Summary: Using single-cell RNA sequencing and multiplex imaging mass cytometry, the authors propose a classification scheme of nine different cancer-associated fibroblast (CAF) subtypes across various cancer types. They validate this scheme in breast cancer samples and further investigate the protein level and spatial distribution of CAFs within tumors. This study provides a useful framework for comparing CAF phenotypes, understanding their functional roles, and potentially guiding future treatment strategies.
NATURE COMMUNICATIONS
(2023)
Review
Oncology
J. Delgado, E. Pean, D. Melchiorri, C. Migali, F. Josephson, H. Enzmann, F. Pignatti
Summary: Entrectinib is a specific inhibitor used for treating NTRK fusion-positive solid tumors and ROS1-positive NSCLC, with clinical trial results showing high treatment efficacy, and common adverse events including dysgeusia, fatigue, dizziness, etc.
Article
Oncology
Ken-ichi Ishiyama, Toshio Kitawaki, Yasuyuki Otsuka, Akifumi Takaori-Kondo, Norimitsu Kadowaki
Summary: Dasatinib treatment can significantly increase the number of NK cells in certain patients, potentially predicting therapeutic response. In CMV-positive patients, the increase in CD56(neg) NK cells may indicate a better clinical outcome and be linked to CMV reactivation.
Article
Cell Biology
Lili Du, Wenbo Deng, Shanshan Zeng, Pei Xu, Lijun Huang, Yingyu Liang, Yang Wang, Hui Xu, Jingman Tang, Shilei Bi, Lizi Zhang, Yulian Li, Luwen Ren, Lin Lin, Weinan Deng, Mingxing Liu, Jingsi Chen, Haibin Wang, Dunjin Chen
Summary: The research shows that abnormal cell composition and communication in the decidua during early pregnancy are associated with RSA, leading to stromal cell demise and pregnancy failure. These findings provide valuable insights for understanding the pathology of RSA and may help in preventing pregnancy loss.
CELL PROLIFERATION
(2021)
Article
Multidisciplinary Sciences
SeungHye Han, Minho Lee, Youngjin Shin, Regina Giovanni, Ram P. Chakrabarty, Mariana M. Herrerias, Laura A. Dada, Annette S. Flozak, Paul A. Reyfman, Basil Khuder, Colleen R. Reczek, Lin Gao, Jose Lopez-Barneo, Cara J. Gottardi, G. R. Scott Budinger, Navdeep S. Chandel
Summary: Alveolar epithelial type 1 (AT1) cells are necessary for gas exchange, while alveolar epithelial type 2 (AT2) cells play a role in lung development and repair. In this study, deleting a specific subunit of the mitochondrial electron transport chain complex I in lung epithelial cells led to abnormal alveolar development and death. Restoring NAD(+) regeneration was able to correct the developmental defects and prevent lethality. These findings highlight the importance of mitochondrial complex I-dependent NAD(+) regeneration in directing cell fate during lung development.
Review
Cell & Tissue Engineering
Nan Hu, Linqing Zou, Cheng Wang, Guoqi Song
Summary: RUNX1T1 plays important roles in acute myeloid leukemia, neuronal development, intestinal development, adipogenesis, angiogenesis, and carcinogenesis, affecting cell fate through transcriptional regulation and signaling pathways.
STEM CELL RESEARCH & THERAPY
(2022)
Article
Multidisciplinary Sciences
Charles Ricordel, L. Chaillot, E. I. Vlachavas, M. Logotheti, A. Jouannic, T. Desvallees, G. Lecuyer, M. Aubry, G. Kontogianni, C. Mastrokalou, F. Jouan, U. Jarry, R. Corre, Y. Le Guen, T. Guillaudeux, H. Lena, A. Chatziioannou, Remy Pedeux
Summary: This study aimed to develop an EpCAM-independent CTC isolation method for the detection of a broader range of living CTC in SCLC and analyze their genomic and biological characteristics. The study found that CD56+ CTC had different mutational profiles and genomic characteristics compared to tumor biopsies in SCLC. Additionally, the study found that the number of CD56+ CTC was correlated with disease extension.
SCIENTIFIC REPORTS
(2023)
Meeting Abstract
Oncology
Judit Moldvay, Katalin Fabian, Marta Jackel, Zsuzsanna Nemeth, Krisztina Bogos, Jozsef Furak, Laszlo Tiszlavicz, Janos Fillinger, Zsuzsa Schaff, Balazs Dome
JOURNAL OF THORACIC ONCOLOGY
(2017)
Article
Oncology
Pin Liu, Diego F. Calvisi, Andras Kiss, Antonio Cigliano, Zsuzsa Schaff, Li Che, Silvia Ribback, Frank Dombrowski, Dongchi Zhao, Xin Chen
Article
Biochemistry & Molecular Biology
Eszter Regos, Hadeer Hesham Abdelfattah, Andrea Reszegi, Laszlo Szilak, Klara Werling, Gabor Szabo, Andras Kiss, Zsuzsa Schaff, Ilona Kovalszky, Kornelia Baghy
Article
Oncology
Timea Szekerczes, Adam Galamb, Adrienn Kocsis, Marta Benczik, Tibor Takacs, Attila Martonos, Balazs Jaray, Andras Kiss, Csaba Jeney, Miklos Nyiri, Zsuzsa Schaff, Gabor Sobel
PATHOLOGY & ONCOLOGY RESEARCH
(2019)
Article
Oncology
Gabor Lendvai, Timea Szekerczes, Benedek Gyongyosi, Krisztina Schlachter, Endre Kontsek, Adrian Pesti, Attila Patonai, Klara Werling, Ilona Kovalszky, Zsuzsa Schaff, Andras Kiss
PATHOLOGY & ONCOLOGY RESEARCH
(2019)
Article
Pathology
Jie Zhang, Pin Liu, Junyan Tao, Pan Wang, Yi Zhang, Xinhua Song, Li Che, Pavel Sumazin, Silvia Ribback, Andras Kiss, Zsuzsa Schaff, Antonio Cigliano, Frank Dombrowski, Carla Cossu, Rosa M. Pascale, Diego F. Calvisi, Satdarshan P. Monga, Xin Chen
AMERICAN JOURNAL OF PATHOLOGY
(2019)
Article
Gastroenterology & Hepatology
Eva Kocsmar, Ildiko Kocsmar, Gyorgy Miklos Buzas, Ildiko Szirtes, Judit Wacha, Alajos Takats, Istvan Hritz, Zsuzsa Schaff, Massimo Rugge, Matteo Fassan, Andras Kiss, Gabor Lotz
Article
Oncology
Farkas Sarnyai, Timea Szekerczes, Miklos Csala, Balazs Sumegi, Andras Szarka, Zsuzsa Schaff, Jozsef Mandl
PATHOLOGY & ONCOLOGY RESEARCH
(2020)
Meeting Abstract
Gastroenterology & Hepatology
E. Kocsmar, I. Kocsmar, G. Buzas, A. Szijarto, L. Bene, J. Wacha, A. Kiss, Z. Schaff, G. Lotz
Meeting Abstract
Gastroenterology & Hepatology
E. Kocsmar, M. Kramer, I. Szirtes, Z. Kramer, I. Kocsmar, G. Rost, G. M. Buzas, A. Szijarto, L. Bene, A. Kiss, Z. Schaff, G. Lotz
Meeting Abstract
Pathology
J. Karczub, E. Kontsek, B. Gyongyosi, Z. Kramer, G. Lendvai, Z. Schaff, A. Kiss
Meeting Abstract
Pathology
E. Kocsmar, I. Kocsmar, M. Kramer, A. Szijarto, G. M. Buzas, L. Bene, I. Szirtes, Z. Kramer, K. Szenas, P. Fadgyas-Freyler, A. Kiss, Z. Schaff, G. Lotz
Meeting Abstract
Pathology
I. Kocsmar, G. Pajor, A. Sziraki, E. Kocsmar, B. Gyongyosi, E. Szekely, I. Kenessey, P. Nyirady, A. Kiss, Z. Schaff, P. Riesz, G. Lotz
Meeting Abstract
Gastroenterology & Hepatology
E. Kocsmar, I. Szirtes, Z. Kramer, I. Kocsmar, A. Szijarto, L. Bene, G. M. Buzas, Z. Schaff, A. Kiss, G. Lotz
Meeting Abstract
Gastroenterology & Hepatology
E. Kocsmar, I. Kocsmar, M. Kramer, L. Katona, P. Fadgyas-Freyler, G. Urban, G. Korponai, A. Kiss, Z. Schaff, G. Lotz